Trump to announce all 50 states joining Medicaid drug pricing model

On Friday, President Trump announced a "most-favored-nation" (MFN) drug pricing program that would bring down prescription costs in Medicaid programs across all 50 states, Washington D.C., and Puerto Rico. The initiative aims to align U.S. drug prices with those in other developed nations, potentially saving state governments $27.6 billion and the federal government $36.6 billion over 10 years. However, experts question whether these savings will directly benefit Medicaid recipients, given that they already receive steep discounts on drugs. The announcement was made as part of Trump's strategy to highlight healthcare achievements ahead of the midterm elections, with the president asserting it would improve services for Americans while freeing up state budgets.